Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiao'er Kechuan Granule dose-finding trial in children with cough variant asthma
ChiCTR-IPR-15006578Phase 2Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of xiaoer kechuanling in cough variant asthma (CVA) (4 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Average daily score of cough severity (daytime plus nighttime). Started Jun 2015; status: recruiting.
02
Drugs
xiaoer kechuanling
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR-IPR-15006578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006578.